Idera Pharmaceuticals Inc news

   Watch this stock
Showing stories 1 - 10 of about 91   

Articles published

IDRA 4.87 -0.27 (-5.25%)
price chart
Idera Pharmaceuticals (IDRA) In A Perilous Reversal
Idera Pharmaceuticals, Inc., a clinical stage biotechnology company, is engaged in the discovery and development of novel therapeutics that modulate immune responses through toll-like receptors (TLRs) in the United States.
Stock to Follow: Idera Pharmaceuticals Inc (NASDAQ:IDRA)  Markets Wired
5 Stock in Different Moves: LKQ Corp. (NASDAQ:LKQ), Idera Pharmaceuticals ...  Property Mentor
Idera Pharmaceuticals (IDRA) Marked As A Dead Cat Bounce Stock
Idera Pharmaceuticals, Inc., a clinical stage biotechnology company, is engaged in the discovery and development of novel therapeutics that modulate immune responses through toll-like receptors (TLRs) in the United States.
Insider Buying: Vincent Milano Purchases 200000 Shares of Idera ...  The Legacy
Related articles »  
Idera Pharmaceuticals: A Star In The Making (IDRA)
Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) is a biotechnology company engaged in discovering and developing Toll-Like Receptors (TLRs) antagonists, novel-synthetic DNA and RNA based drug candidates.
Related articles »  
Idera Pharmaceuticals Inc. (IDRA) is Trading Lower on Unusual Volume for ...
Idera Pharmaceuticals Inc. ($IDRA) experienced unusually high volume on Feb. 27, as the stock lost 5.25% to a closing price of $4.87.
Idera Pharmaceuticals Inc (NASDAQ:IDRA) in Spotlight
[Globe Newswire] Idera Pharmaceuticals Inc (NASDAQ:IDRA) (TREND ANALYSIS), announced the pricing of an underwritten public offering of 20,000,000 shares of common stock for a public offering price of $3.75 per share.
Share Price of Idera Pharmaceuticals Inc Rally 1.99%  Ashburn Daily
Idera Pharmaceuticals Inc Registers High Short Interest  Wall Street Pulse
Company Shares of Idera Pharmaceuticals Inc Rally 13.66%
Shares of Idera Pharmaceuticals Inc (NASDAQ:IDRA) rose by 13.66% in the past week and 3.33% for the last 4 weeks. In the past week, the counter has outperformed the S&P 500 by 12.94% and the outperformance increases to 0.46% for the last 4 weeks.
Stocks Alert: Idera Pharmaceuticals Inc (NASDAQ:IDRA), Cempra Inc (NASDAQ ...  Market News Call
Healthcare Sector Movers: Idera Pharmaceuticals, Inc. (IDRA), Pharmacyclics ...  WallStreet Scope
Idera Pharmaceuticals Going Into 2015 (IDRA)
Idera Pharmaceuticals Inc. (NASDAQ:IDRA) is set to enter 2015 with a number of important developments happening during the year.
Related articles »  
Idera Pharmaceuticals Inc. (IDRA) Jumps 5.11% on February 26
Idera Pharmaceuticals Inc. ($IDRA) was among the biggest gainers on the Russell 2000 for Thursday February 26 as the stock popped 5.11% to $5.14, representing a gain of $0.25 per share.
Price Target Update on Idera Pharmaceuticals Inc
Idera Pharmaceuticals Inc (NASDAQ:IDRA): 1 Analyst have given the stock of Idera Pharmaceuticals Inc (NASDAQ:IDRA) a near short term price target of $7.
Stock Watch: Idera Pharmaceuticals Inc (NASDAQ:IDRA)
[Globe NewsWIRE] Idera Pharmaceuticals Inc (NASDAQ:IDRA) (TREND ANALYSIS), a clinical-stage biopharmaceutical company developing immune-modulating and gene silencing therapies for cancer and rare diseases, today announced the appointments ...
Shares of Idera Pharmaceuticals Inc Soars by 0.22% for the Week  Ashburn Daily
Idera Pharmaceuticals Inc Registers High Short Percent of Float  Stafford Daily